Sofinnova Investments, Inc. Amylyx Pharmaceuticals, Inc. Put Options Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
Put Options
1 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
44.6MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$12.1 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.34MShares$9.59 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$7.66 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$7.49 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.9MShares$5.46 Million1.57% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $168M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...